• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket

    6/14/23 8:07:03 AM ET
    $AGRX
    $AHI
    $BRSH
    $CNVS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $AGRX alert in real time by email

    Gainers

    • Cyxtera Technologies, Inc. (NASDAQ:CYXT) shares rose 134.6% to $0.0981 in pre-market trading after dropping 12% on Tuesday.
    • WiSA Technologies, Inc. (NASDAQ:WISA) shares surged 44.2% to $1.86 in pre-market trading. WiSA Technologies started taking pre-orders for WiSA E multichannel audio development kits.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares gained 32% to $0.0822 in pre-market trading. T2 Biosystems recently reported a clinical collaboration with Vanderbilt University Medical Center to implement and evaluate the T2Bacteria panel for clinical use.
    • Oncorus, Inc. (NASDAQ:ONCR) gained 27.5% to $0.0931 in pre-market trading after declining around 10% on Tuesday. The company’s board of directors approved liquidation and it will be suspended from NASDAQ from 20 June.
    • Inventiva S.A. (NASDAQ:IVA) gained 24% to $4.55 in pre-market trading after the company announced its Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD achieved its primary efficacy endpoint.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) shares climbed 21.7% to $4.37 in pre-market trading. Agile Therapeutics reported a new agreement with VitaCare Prescription Services to improve access to Twirla.
    • Kuke Music Holding Limited (NYSE:KUKE) shares rose 16.1% to $0.7780 in pre-market trading.
    • NightHawk Biosciences, Inc. (NYSE:NHWK) shares gained 12.6% to $0.7001 in pre-market trading.
    • NextDecade Corporation (NASDAQ:NEXT) rose 11.9% to $5.74 in pre-market trading. NextDecade reported framework agreements with Global Infrastructure Partners and TotalEnergies to support the development of the Rio Grande LNG project.
    • Nikola Corporation (NASDAQ:NKLA) rose 10.5% to $1.01 in pre-market trading after jumping over 19% on Tuesday.

    Losers

    • Eastside Distilling, Inc (NASDAQ:EAST) fell 31.9% to $4.24 in pre-market after the company disclosed business and financial updates.
    • Cineverse Corp. (NASDAQ:CNVS) fell 30.1% to $2.49 in pre-market trading after the company reported a proposed public offering.
    • Medigus Ltd. (NASDAQ:MDGS) fell 22.1% to $6.40 in pre-market trading.
    • Advanced Health Intelligence Ltd. (NASDAQ:AHI) fell 20.7% to $1.19 in pre-market trading after dropping over 37% on Tuesday. Advanced Health Intelligence said it will undertake AUD$5 million private placement.
    • The OLB Group, Inc. (NASDAQ:OLB) shares dropped 18.8% to $0.7709 in pre-market trading after jumping around 42% on Tuesday.
    • Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shares dropped 15.8% to $1.39 in pre-market trading after gaining over 4% on Tuesday.
    • IperionX Limited (NASDAQ:IPX) shares fell 13.7% to $11.40 in pre-market trading. IperionX shares climbed over 100% on Tuesday after the company announced it will produce titanium components for the Ford Motor Company.
    • Cyclo Therapeutics, Inc. (NASDAQ:CYTH) fell 13.1% to $2.00 in pre-market trading after jumping over 18% on Tuesday. The European Patent Office allowED patent for Trappsol Cyclo for Alzheimer's Disease.
    • MicroVision, Inc. (NASDAQ:MVIS) fell 12.7% to $5.56 in pre-market trading after the company filed for a mixed shelf offering.
    • Bruush Oral Care Inc. (NASDAQ:BRSH) fell 12.5% to $0.3320 in pre-market trading after jumping over 22% on Tuesday.

     

    Now Read This: Investor Sentiment Improves Further Following Inflation Report

    Get the next $AGRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRX
    $AHI
    $BRSH
    $CNVS

    CompanyDatePrice TargetRatingAnalyst
    IperionX Limited
    $IPX
    3/27/2026$40.00Buy
    BTIG Research
    Inventiva S.A.
    $IVA
    3/19/2026$13.00Buy
    Truist
    NextDecade Corporation
    $NEXT
    3/5/2026$7.00 → $6.00Hold
    TD Cowen
    Cineverse Corp.
    $CNVS
    2/19/2026$12.00Speculative Buy → Buy
    The Benchmark Company
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    Inventiva S.A.
    $IVA
    1/28/2026$18.00Overweight
    Barclays
    IperionX Limited
    $IPX
    1/13/2026Outperform
    William Blair
    Inventiva S.A.
    $IVA
    1/12/2026$12.00Outperform
    Leerink Partners
    More analyst ratings

    $AGRX
    $AHI
    $BRSH
    $CNVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on IperionX with a new price target

    BTIG Research initiated coverage of IperionX with a rating of Buy and set a new price target of $40.00

    3/27/26 8:50:54 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    Truist initiated coverage on Inventiva with a new price target

    Truist initiated coverage of Inventiva with a rating of Buy and set a new price target of $13.00

    3/19/26 8:26:25 AM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TD Cowen reiterated coverage on NextDecade with a new price target

    TD Cowen reiterated coverage of NextDecade with a rating of Hold and set a new price target of $6.00 from $7.00 previously

    3/5/26 7:46:59 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AGRX
    $AHI
    $BRSH
    $CNVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres Tech/Chief Product Off Huidor Mark Antonio bought $75,000 worth of shares (37,500 units at $2.00), increasing direct ownership by 25% to 190,061 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:57:19 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    CFO Lindsey Mark Wayne bought $70,000 worth of shares (35,000 units at $2.00), increasing direct ownership by 29% to 154,168 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:43 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Chief Motion Pictures Officer Macias Yolanda sold $5,297 worth of shares (2,189 units at $2.42) and bought $60,000 worth of shares (30,000 units at $2.00), increasing direct ownership by 30% to 121,760 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:04 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AGRX
    $AHI
    $BRSH
    $CNVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cineverse Celebrates Halfway to Halloween with Harrowing Holiday Horror Flick, Silent Night, Deadly Night Exclusively Streaming On SCREAMBOX

    The Fan-Favorite Holiday Slasher, Certified Fresh On Rotten Tomatoes, is Coming To SCREAMBOX on April 28thMore New Blood is Added To the SCREAMBOX Slate Including New Seasons Of Bloody Bites, and Films Monkey's Magic Merry Go Round, DRAGN and More!LOS ANGELES, April 1, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), an entertainment technology company and studio, has announced today that SCREAMBOX will be the exclusive streaming home of Silent Night, Deadly Night, starting on April 28th. The film is currently available on digital EST/TVOD and is Certified Fresh on Rotten Tomatoes.

    4/1/26 12:40:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    Inventiva reports 2025 full year results and provides a business update

    Revenues of €4.5 million for the full year of 2025Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits1 as at December 31, 2025Completed a U.S. registered public offering for gross proceeds of approximately $172.5 million (€149 million2)Cash runway expected until the middle of the first quarter of 20273Completed the sale of odiparcil with potential milestone payments of up to $90 million and potential royalties on future net sales, if approvedTopline results of NATiV3 Phase 3 clinical trial expected for the fourth quarter of 2026The Company will host a conference call on March 31, 2026, at 8 a.m. EDT / 2 p.m. CEST Daix (France), New York City (New York, Uni

    3/30/26 4:11:03 PM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Iperionx – Change of Directors and Officers Ownership

    SOUTH BOSTON, Va., March 30, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (IperionX) (NASDAQ:IPX, ASX: IPX)) has lodged filings with the Securities and Exchange Commission and the Australian Securities Exchange relating to changes in Directors' and Officer's ownership in IperionX. A summary of the changes can be found below. Director / OfficerNo. of Securities AcquiredValue / ConsiderationValue / Consideration (US$)1Anastasios ARIMA467,000 Shares12,800 ADSsA$1,493,480.25(Shares) US$299,643.64 (ADSs)US$1,331,787.84Todd HANNIGAN225,225 SharesA$720,917.30US$498,225.95R. Tony TRIPENY4,187 ADSsUS$99,463.67US$99,463.67Toby SYMONDS11,000 ADSsUS$262,552.40US$262,552.40 1. Converted from A$ to US$ us

    3/30/26 9:51:44 AM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    $AGRX
    $AHI
    $BRSH
    $CNVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Castro Marcela Rocha

    4 - IPERIONX Ltd (0001898601) (Issuer)

    4/2/26 8:08:47 PM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    SEC Form 4 filed by Symonds Toby Edgcumbe

    4 - IPERIONX Ltd (0001898601) (Issuer)

    4/2/26 7:56:41 PM ET
    $IPX
    Other Metals and Minerals
    Basic Materials

    SEC Form 4 filed by Devos Glen W.

    4 - MICROVISION, INC. (0000065770) (Issuer)

    4/2/26 7:36:03 PM ET
    $MVIS
    Industrial Machinery/Components
    Technology

    $AGRX
    $AHI
    $BRSH
    $CNVS
    SEC Filings

    View All

    SEC Form 10-K filed by The OLB Group Inc.

    10-K - OLB GROUP, INC. (0001314196) (Filer)

    3/31/26 9:41:11 PM ET
    $OLB
    Real Estate

    SEC Form NT 10-K filed by The OLB Group Inc.

    NT 10-K - OLB GROUP, INC. (0001314196) (Filer)

    3/31/26 8:37:10 PM ET
    $OLB
    Real Estate

    SEC Form 6-K filed by Inventiva S.A.

    6-K - Inventiva S.A. (0001756594) (Filer)

    3/30/26 5:33:15 PM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGRX
    $AHI
    $BRSH
    $CNVS
    Leadership Updates

    Live Leadership Updates

    View All

    Cineverse and GameStop Invite Fans to 'Return to Silent Hill' with Innovative Partnership featuring Mysterious Messages, Exclusive Rewards, In-Store Media & More

    Return to Silent Hill Hits Theaters Nationwide on January 23 – Buy Tickets Now LOS ANGELES and GRAPEVINE, Texas, Jan. 14, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next generation entertainment studio, and GameStop Corp. (NYSE:GME), are pulling out all the stops in anticipation of the January 23 wide theatrical release of Return to Silent Hill (returntosilenthillmovie.com).  The two companies are collaborating on an immersive marketing campaign for the new film, based on the visionary video game, SILENT HILL 2. Since January 7, fans who visit a participating GameStop ca

    1/14/26 3:02:00 PM ET
    $CNVS
    $GME
    Consumer Electronics/Video Chains
    Consumer Discretionary
    Electronics Distribution

    Einride, a Leader in Electric and Autonomous Freight, Appoints Anubhav Verma as Chief Financial Officer Ahead of Planned Public Listing

    STOCKHOLM, Nov. 24, 2025 /PRNewswire/ -- Einride AB, a technology company driving the transition to electric and autonomous freight operations for some of the world's largest shippers ("Einride" or the "Company"), today announced the appointment of Anubhav Verma as Chief Financial Officer in preparation for the Company's planned public listing on the New York Stock Exchange via its proposed business combination with Legato Merger Corp. III (NYSEAMERICAN: LEGT), a special purpose acquisition company ("Legato"). Verma, whose appointment will become effective in January 2026, brings over 16 years of global experience in capital markets, mergers and acquisitions, and strategic finance. Most rec

    11/24/25 6:55:00 AM ET
    $MVIS
    Industrial Machinery/Components
    Technology

    NextDecade Announces Chief Financial Officer Transition

    NextDecade Corporation (NextDecade or the Company) (NASDAQ:NEXT) announced today that Brent Wahl, Chief Financial Officer, has resigned from the Company effective October 20, 2025, and the Company has appointed Mike Mott, Senior Vice President Enterprise Transformation, as Interim Chief Financial Officer effective October 20, 2025. Mr. Wahl is leaving NextDecade to join a digital infrastructure company, and he has agreed to serve in a consultant capacity through December 31, 2025, to facilitate a seamless transition. The Company will initiate a comprehensive search process to find a permanent successor. "I want to thank Brent for the significant impact he has made at NextDecade," said M

    10/8/25 8:00:00 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AGRX
    $AHI
    $BRSH
    $CNVS
    Financials

    Live finance-specific insights

    View All

    Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results

    Daix (France), New York (United States), March 23, 2026 – Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis ("MASH"), today announced that it will release its 2025 full-year financial results on Monday, March 30, 2026, after market close in the United States. Inventiva's management will hold a conference call in English, followed by a Q&A session, on Tuesday, March 31, 2026, at 8:00 am (New York), 2:00 pm (Paris). Participants wishing to join the conference call by phone and ask questions must register in advance here. Upon regis

    3/23/26 5:00:00 PM ET
    $IVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NextDecade Provides Fourth Quarter 2025 Business Update

    NextDecade Corporation (NextDecade or the Company) (NASDAQ:NEXT) today provided an update on developmental and strategic activities for the fourth quarter 2025 and early first quarter 2026. CEO Commentary "In 2025, we commercialized and achieved positive final investment decisions (FIDs) on Trains 4 and 5 at the Rio Grande LNG Facility with strong expected economic returns, illustrating the robust value and competitiveness of our liquefaction capacity," said Matt Schatzman, NextDecade Chairman and CEO. "With 30 million tonnes per annum (MTPA) of expected LNG production capacity under construction and the goal of doubling our capacity to 60 MTPA on site, growth at attractive returns cont

    3/2/26 8:00:00 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Cineverse Reports Third Quarter Fiscal Year 2026 Results

    Total Revenue of $16.3 MillionDirect Operating Margin of 69%, compared to 48% in Prior Year QuarterAdjusted EBITDA of $2.4 MillionAnnounces Guidance of $115 to $120 Million of Revenue and $10 to $20 Million of Adjusted EBITDA for Fiscal Year 2027, Commencing April 1, 2026LOS ANGELES, Feb. 17, 2026 /PRNewswire/ -- Cineverse Corp. ("Cineverse" or the "Company") (NASDAQ:CNVS), a global streaming technology and entertainment company, today announced its financial results for its fiscal third quarter ended December 31, 2025 ("Q3 FY 2026"): Acquisitions (Subsequent Events)Subsequent t

    2/17/26 4:00:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AGRX
    $AHI
    $BRSH
    $CNVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by WiSA Technologies Inc.

    SC 13G - WISA TECHNOLOGIES, INC. (0001682149) (Subject)

    11/14/24 5:27:55 PM ET
    $WISA
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by The OLB Group Inc.

    SC 13G/A - OLB GROUP, INC. (0001314196) (Subject)

    11/14/24 5:17:38 PM ET
    $OLB
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Coeptis Therapeutics Holdings Inc.

    SC 13G/A - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)

    11/14/24 3:59:49 PM ET
    $COEP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care